Skip to content
Hemostemix Inc. episode artwork

EPISODE · Dec 18, 2023 · 11 MIN

Hemostemix Inc.

from OTCQB Podcast · host OTC Markets Group

Hemostemix Inc. (OTCQB: HMTXF) is a patient's own stem cell therapy company that holds 91 patents. A winner of the World Economic Forum Technology Pioneer Award, the Company has developed patented, and is scaling a patient's blood-based stem cell therapeutics platform. Thomas Smeenk, President, CEO and Co-Founder of Hemostemix, joins us today to share his personal story and inspiration for creating this company to help others. View Podcast Transcript

Episode metadata supplied by the publisher feed · Published Dec 18, 2023

Embed this episode

Ready to play

Hemostemix Inc.

0:00 11:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of OTCQB Podcast?

This episode is 11 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on December 18, 2023.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!